Target intelligence / Profile preview

Lipid hydroperoxide (LOOH)

Target
LOOH
Molecular classification
Other
01

Overview

Lipid hydroperoxides are primary oxidation products formed when lipids—especially polyunsaturated fatty acids in biological membranes—undergo peroxidation due to attack by reactive oxygen species such as hydroxyl radicals or singlet oxygen. The process involves three phases: initiation, propagation, and termination. During propagation, lipid radicals react with molecular oxygen to form lipid peroxyl radicals and ultimately lipid hydroperoxides. These molecules are more polar than their parent lipids and can disrupt membrane structure and function[8]. They serve as intermediates in oxidative stress responses and can be further reduced enzymatically by glutathione peroxidases or degraded into secondary products like aldehydes (e.g., malondialdehyde [MDA], 4-hydroxynonenal [4-HNE]), which themselves have significant biological activity including acting as signaling molecules or inducing cell death pathways such as ferroptosis[2][5]. Accumulation of lipid hydroperoxides is implicated in the pathogenesis of various diseases including cancer, neurodegeneration, cardiovascular diseases, inflammation-related conditions, and skin disorders due to their ability to perturb cellular membranes and modulate redox-sensitive signaling pathways[2][5][8]. While not a classical therapeutic target like a receptor or enzyme but rather a class of reactive metabolites/biomarkers produced during oxidative damage processes—they are important both mechanistically in disease biology and diagnostically for monitoring oxidative stress states[1][2][7].

Other names
Lipid peroxideLOOHlipid hydroperoxides (plural)phospholipid hydroperoxidecholesterol hydroperoxide (ChOOH)squalene hydroperoxide (SQOOH)
02

Biological functions

Oxidative stress mediatorMembrane structure modulationCell signaling moleculeInducer of cell death pathways (e.g., ferroptosis)Precursor to secondary reactive products
03

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationSkin disorders
04

Biomarkers

Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)TBARS assay for lipid peroxidation end-products

Beyond the preview

Go deeper on Lipid hydroperoxide (LOOH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid hydroperoxide (LOOH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call